Dr. Antoine Duquette

Associate Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Antoine Duquette. Improve your application with a focused, well-structured draft.

Biography

Antoine Duquette is a neurologist at the Centre hospitalier de l’Université de Montréal (CHUM) and an associate professor in the Department of Neurosciences at the Faculty of Medicine Université de Montréal. He specializes in movement disorders, focusing on spinocerebellar ataxias and hereditary neurodegenerative diseases. He also participates in the gene medicine service at CHUM as a neurology consultant. Duquette earned his medical degree from Université de Montréal in 2002. During his residency in neurology, he completed a Master's degree in Neurosciences focusing on a Franco-Canadian form of autosomal recessive ataxia. After finishing his residency in 2008, he pursued additional clinical training and research in movement disorders at McGill University. He further specialized at Brigham Women’s Hospital affiliated with Harvard University, where he studied neurodegeneration mechanisms in Drosophila. Throughout his training, he received support from a Phase 1 clinician-researcher grant from the Canadian Institutes of Health Research (CIHR) and various scholarships from research funds in Quebec. His research interests include understanding genetic factors contributing to neurodegeneration during aging and utilizing Drosophila as a model for human neurodegenerative diseases.

Research Interests

Requirements for Université de Montréal

Doctorate Program
Requirements
GPA Requirement
Required:3.3
TOEFL
Listening
Required:20
Reading
Required:20
Writing
Required:20
Speaking
Required:20
Total
Required:90
Prerequisites
MSc in Pharmacology or equivalent Research supervisor confirmation
Application Checklist
  • Transcripts
  • Birth certificate
  • Curriculum Vitae
  • Proof of French proficiency (B2/C1)
Specialization Notes

Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.